Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Intraocular Pressure Reduction with NCX 470 versus Latanoprost Across the Spectrum of Baseline Intraocular Pressures

March 5, 2024

View Press Release Corporate presentation Contact us
Previous